Literature DB >> 8109277

The possible role of the cerebral cortex adjacent to the central sulcus for the genesis of central (thalamic) pain--a metabolic study.

M Hirato1, S Horikoshi, Y Kawashima, K Satake, T Shibasaki, C Ohye.   

Abstract

In nine patients with central (thalamic) pain after stroke, X-CT, MRI, PET scan and intraoperative thalamic microrecordings were performed. The PET studies made use of Sokoloff's method with 18FDG and a steady-state method with C15O2-15O2. CT scan and MRI revealed definite thalamic damage (Th) in 3 cases, putaminal damage (Put) in 3 cases, combined damage (Th + Put) in one case, and cortical (parietal) damage in 2 cases. In patients with a subcortical lesion, the greater the severity of superficial pain, the higher was the relative value of regional cerebral glucose metabolism (rCMRGlu) as compared to oxygen metabolism (rCMRO2) in the cerebral cortex around the central sulcus on the damaged side. Also, in a case with combined (Th + Put) lesion, regional oxygen extraction ratio (rOEF) was increased in this area. Moreover, in another case, central pain disappeared after a small subcortical haemorrhage in the same structure. In all patients including those with a cortical lesion, rCMRGlu was decreased in the postero-lateral (sensory) thalamus on the invalued side. The possible role of the cerebral cortex around the central sulcus for the genesis of central pain is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8109277     DOI: 10.1007/978-3-7091-9297-9_32

Source DB:  PubMed          Journal:  Acta Neurochir Suppl (Wien)


  2 in total

1.  Long-term changes in behavior and regional cerebral blood flow associated with painful peripheral mononeuropathy in the rat.

Authors:  Pamela E Paulson; Kenneth L Casey; Thomas J Morrow
Journal:  Pain       Date:  2002-01       Impact factor: 6.961

2.  Abnormal activity of primary somatosensory cortex in central pain syndrome.

Authors:  Raimi L Quiton; Radi Masri; Scott M Thompson; Asaf Keller
Journal:  J Neurophysiol       Date:  2010-07-21       Impact factor: 2.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.